PATENT CLAIM ANALYSIS

Application Number: 16078155
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "249000"]

Abstract:
Compounds of formula (I) wherein A, R, W, Q, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

Claim (Index 7):
A compound of formula I according to  claim 1  to  claim 6 , wherein R 5 , R 6 , R 7  are independently H, Hal, NR 3 R 4 , NH 2 , N(CH 3 ) 2 , phenyl, 2-, 3- or 4-hydroxy or methoxyphenyl, alkyl, CF 3 , alkoxy (Oalkyl), hydroxyalkylen, alkoxyalkylen, COOH, COOalkyl, CONHalkyl, CONH 2 , CON(CH 3 ) 2 , NHCOalkyl, NHalkyl, CO\u2014N-morpholinyl, CON(CH 3 )CH 2 CH 2 N(CH 3 ) 2 , CO-1-piperidinyl, CO-4-hydroxy-1-piperidinyl, CO-1-piperazinyl, CO-4-methyl-1-piperazinyl, CH 2 \u2014N-morpholinyl, CH 2 N(H)COCH 3 , CH 2 N(CH 3 )COCH 3 , substituted or unsubstituted Cyc or Het.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 96.0
- Lexical Diversity: 1.27273
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14502213', '14131471', '14775134', '15830675', '13515598']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8058670662733818
- 35 USC 102 Novelty (BERT): 0.5446396105516638
- Combined Prediction Score: 0.77974432070121
- Mean Citation Score: 355.667998
- Max Citation Score: 387.89282
- Similarity Product: 291.373927200129

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test